Taken together, this suggests that glucose influx by GLUT1 alone is not sufficient to accelerate plaque progression and that the effect of hyperglycemia on increasing myelopoiesis and recruitment of monocytes and neutrophils to the lesion may be driven by additional factors [53]. This evidence concerns the gene SLC2A1 and Hyperglycemia.